Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Other Accumulated Expenses (2023 - 2025)

Historic Other Accumulated Expenses for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $630000.0.

  • Profound Medical's Other Accumulated Expenses changed N/A to $630000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $630000.0, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2024, which is 7968.13% up from last year.
  • Per Profound Medical's latest filing, its Other Accumulated Expenses stood at $630000.0 for Q3 2025.
  • Profound Medical's Other Accumulated Expenses' 5-year high stood at $1.8 million during Q4 2024, with a 5-year trough of $509000.0 in Q2 2025.
  • In the last 3 years, Profound Medical's Other Accumulated Expenses had a median value of $955000.0 in 2025 and averaged $980400.0.
  • The largest annual percentage gain for Profound Medical's Other Accumulated Expenses in the last 5 years was 7968.13% (2024), contrasted with its biggest fall of 7968.13% (2024).
  • Quarter analysis of 3 years shows Profound Medical's Other Accumulated Expenses stood at $1.0 million in 2023, then surged by 79.68% to $1.8 million in 2024, then crashed by 65.08% to $630000.0 in 2025.
  • Its last three reported values are $630000.0 in Q3 2025, $509000.0 for Q2 2025, and $955000.0 during Q1 2025.